Abstract
Purpose
To explore the application value of multi-slice spiral CT (MSCT), magnetic resonance imaging (MRI) combined with gastric contrast-enhanced ultrasonography in the diagnosis of T staging of gastric cancer.
Methods
The subjects of study were 109 gastric cancer patients with T stages admitted to our hospital for diagnosis and treatment from December 2016 to December 2018. All the patients were examined with MSCT, MRI and gastric contrast-enhanced ultrasonography before operation to observe corresponding imaging results. T staging of gastric cancer patients was conducted according to the examination results, which was then compared with postoperative pathological staging. It was performed to analyze the accuracy of the three diagnostic methods and combined diagnosis of gastric cancer T staging.
Results
The sensitivity of MSCT in the diagnosis of T staging of gastric cancer was 60.00%, 67.74%, 72.22%, 76.47%, the specificity was 95.24%, 88.46%, 86.30%, 94.56% and the diagnostic coincidence rate was 87.16%, 82.57%, 81.65%, 91.74%; the sensitivity of MRI in the diagnosis of T staging of gastric cancer was 68.00%, 70.97%, 77.78%, 76.47%, the specificity was 92.86%, 88.46%, 91.78%, 95.65%, and the diagnostic coincidence rate was 87.16%, 83.49%, 87.16%, 92.66%; the sensitivity of gastric contrast-enhanced ultrasonography in the diagnosis of T staging of gastric cancer was 80.00%, 83.87%, 86.11%, 82.35%, the specificity was 97.62%, 92.31%, 91.78%, 97.83%, and the diagnostic coincidence rate was 93.58%, 89.91%, 89.91%, 95.41%; the sensitivity of combined MSCT, MRI and gastric contrast-enhanced ultrasonography in the diagnosis of T staging of gastric cancer was 88.00%, 93.55%, 97.22%, 94.12%; the specificity was 100%, 97.44%, 95.89%, 98.91%; and the diagnostic coincidence rate was 97.25%, 96.33%, 96.33%, 98.17%, respectively. Statistical analysis revealed that the sensitivity, specificity and diagnostic coincidence rate of combined detection of the three methods were significantly higher than those of single detection (P < 0.05).
Conclusion
Combined use of MSCT, MRI and gastric contrast-enhanced ultrasonography can significantly improve the diagnostic sensitivity, specificity and diagnostic coincidence rate of T staging of gastric cancer. It may provide a certain reference value for guiding the selection of clinical therapeutic approaches and evaluation of curative effect.
Similar content being viewed by others
References
Kwee RM, Kwee TC. Imaging in local staging of gastric cancer: a systematic review. J ClinOncol. 2007;25:2107–16.
Lo SS, Wu CW, Chen JH, et al. Surgical results of early gastric cancer and proposing a treatment strategy. Ann SurgOncol. 2007;14:340–7.
Furukawa K, Miyahara R, Itoh A, et al. Diagnosis of the invasion depth of gastric cancer using MDCT with virtual gastroscopy: comparison with staging with endoscopic ultrasound. AJR Am J Roentgenol. 2011;197:867–75.
Venkataraman I, Rao HK, Singh P, Elangovan S, Kate V. Efficacy of hydrogastricsonography and spiral computed tomography in staging of gastric carcinoma–a comparative study. J Clin Ultrasound. 2010;38:480–5.
Kim IY, Kim SW, Shin HC, Lee MS, Jeong DJ, Kim CJ, Kim YT. MRI of gastric carcinoma: results of T and N-staging in an in vitro study. World J Gastroenterol. 2009;15:3992–8.
Amin MB, Edge SB, Greene FL, et al. AJCC cancer staging manual. 8th ed. New York: Springer; 2016. p. 203–20.
Seevaratnam R, Cardoso R, McGregor C, Lourenco L, Mahar A, Sutradhar R, Law C, Paszat L, Coburn N. How useful is preoperative imaging for tumor, node, metastasis (TNM) staging of gastric cancer? A meta-analysis. Gastric Cancer. 2012;15:S3-18.
Hallinan JT, Venkatesh SK. Gastric carcinoma: imaging diagnosis, staging and assessment of treatment response. Cancer Imaging. 2013;13:212–27.
Liu B, Ramalho M, AlObaidy M, et al. Gastrointestinal imagingpractical magnetic resonance imaging approach. World J Radiol. 2014;6:544.
Wang CK, Kuo YT, Liu GC, et al. Dynamic contrast- enhanced subtraction and delayed MRI of gastric tumors: radiologic-pathologic correlation. J Comput Assist Tomogr. 2000;24:872–7.
Arslan H, FatihÖzbay M, Çallı İ, Doğan E, Çelik S, Batur A, Bora A, Yavuz A, Bulut MD, Özgökçe M, Çetin KM. Contribution of diffusion weighted MRI to diagnosis and staging in gastric tumors and comparison with multi-detector computed tomography. RadiolOncol. 2017;51:23–9.
Maccioni F, Marcelli G, Al Ansari N, Zippi M, De Marco V, Kagarmanova A, Vestri A, Marcheggiano-Clarke L, Marini M. Preoperative T and N staging of gastric cancer: magnetic resonance imaging (MRI) versus multi detector computed tomography (MDCT). ClinTer. 2010;161:e57-62.
Sohn KM, Lee JM, Lee SY, et al. Comparing MR image and CT in the staging of gastric carcinoma. AJR Am J Roentgenol. 2000;174:1551–7.
Kang BC, Kim JH, Kim KW, et al. Value of the dynamic and delayed MR sequence with Gd-DTPA in the T-staging of stomach cancer: correlation with the histopathology. Abdom Imaging. 2000;25:14–24.
Lee SL, Ku YM, Jeon HM, et al. Impact of the cross-sectional location of multi-detector computed tomography scans on prediction of serosalexposurein patients with advanced gastric cancer. Ann SurgOncol. 2017;24:1003–9.
Motohara T, Semelka RC. MRI in staging of gastric cancer. Abdom Imaging. 2002;27:376–83.
Huo X, Yuan K, Shen Y, Li M, Wang Q, Xing L, Shi G. Clinical value of magnetic resonance imaging in preoperative T staging of gastric cancer and postoperative pathological diagnosis. OncolLett. 2014;8:275–80.
Li JH, Shen WZ, Gu XQ, Hong WK, Wang ZQ. Prognostic value of EUS combined with MSCT in predicting the recurrence and metastasis of patients with gastric cancer. Jpn J ClinOncol. 2017;47:487–93.
Kadowaki K, Murakami T, Yoshioka H, et al. Helical CT imaging of gastric cancer: normal wall appearance and the potential for staging. Radiat Med. 2000;18:47–54.
D’Elia F, Zingarelli A, Palli D, et al. Hydro-dynamic CT preoperative staging of gastric cancer: correlation with pathological findings. A prospective study of 107 cases. EurRadiol. 2000;10:1877–85.
Habermann CR, Weiss F, Riecken R, et al. Preoperative staging of gastric adenocarcinoma: comparison of helical CT and endoscopic US. Radiology. 2004;230:465–71.
Hwang SW, Lee DH, Lee SH, et al. Preoperative staging of gastric cancer by endoscopic ultrasonography and multidetectorrow computed tomography. J GastroenterolHepatol. 2010;25:512–8.
Ang J, Hu L, Huang PT, et al. Contrast-enhanced ultrasonography assessment of gastric cancer response to neoadjuvant chemotherapy. World J Gastroenterol. 2012;18:7026–32.
Wei F, Huang P, Li S, et al. Enhancement patterns of gastric carcinoma on contrast-enhanced ultrasonography: relationship with clinicopathological features. PLoS ONE. 2013;8:e73050.
Arocena MG, Barturen A, Bujanda L, et al. MRI and endoscopic ultrasonography in the staging of gastric cancer. Rev EspEnferm Dig. 2006;98:582–90.
Hwang SW, Lee DH, Lee SH, et al. Preoperative staging of gastric cancer by endoscopic ultrasonography and multidetector-row computed tomography. J GastroenterolHepatol. 2010;25:512–8.
Author information
Authors and Affiliations
Contributions
QG and XL conceived the study and drafted the manuscript. NL and LL contributed to the acquisition, analysis, or interpretation of data for the work. ZM and AC were responsible for MSCT examination, MRI examination and pathological examination. All authors finally approved the manuscript version to be published.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
The study was approved by Ethical Committee of Yantaishan Hospital and conducted in accordance with the ethical standards.
Informed consent
Subjects signed the informed consent.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Gai, Q.Z., Li, X.L., Li, N. et al. Clinical significance of multi-slice spiral CT, MRI combined with gastric contrast-enhanced ultrasonography in the diagnosis of T staging of gastric cancer. Clin Transl Oncol 23, 2036–2045 (2021). https://doi.org/10.1007/s12094-021-02606-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-021-02606-9